Proteolysis-targeting chimeras in antiviral therapy: Leveraging influenza virus and exosome-mediated delivery for targeted protein degradation and therapeutic advancements

被引：2
|
作者：
Mukerjee, Nobendu [1 ,2 ]
Maitra, Swastika [3 ]
Sharma, Rohit [4 ]
机构：
[1] Saveetha Inst Med Tech Sci, Saveetha Med Coll & Hosp, Ctr Global Hlth Res, Chennai, India
[2] Novel Global Community Educ Fdn, Dept Hlth Sci, Hebersham, NSW, Australia
[3] Adamas Univ, Dept Microbiol, Kolkata, W Bengal, India
[4] Banaras Hindu Univ, Inst Med Sci, Fac Ayurveda, Dept Rasa Shastra & Bhaishajya Kalpana, Varanasi, Uttar Pradesh, India
来源：
DRUG DEVELOPMENT RESEARCH | 2024年 / 85卷 / 01期
关键词：
antiviral therapy; exosomes; influenza virus; PROTACs; MOLECULES;
D O I：
10.1002/ddr.22145
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页数：7
相关论文
共 11 条
  • [1] Proteolysis-targeting chimeras: a kaleidoscope of targeted protein degradation
    Mou, Yi
    Wen, Shuai
    Gao, Xinxing
    Jiang, Zheng-Yu
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (03) : 139 - 141
  • [2] Proteolysis-Targeting Chimeras: Induced Protein Degradation as a Therapeutic Strategy
    Ottis, Philipp
    Crews, Craig M.
    ACS CHEMICAL BIOLOGY, 2017, 12 (04) : 892 - 898
  • [3] Integrating Proteolysis-Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
    Lin, Jiachan
    Chen, Zirui
    Zhang, Dan
    Zhang, Nan
    Chen, Hongzhong
    Guo, Dong-Sheng
    MACROMOLECULAR RAPID COMMUNICATIONS, 2025,
  • [4] Synergizing Proteolysis-Targeting Chimeras and Nanoscale Exosome-Based Delivery Mechanisms for HIV and Antiviral Therapeutics
    Mukerjee, Nobendu
    Maitra, Swastika
    Ghosh, Arabinda
    Sengupta, Tapti
    Alexiou, Athanasios
    Subramaniyan, Vetriselvan
    Anand, Krishnan
    ACS APPLIED NANO MATERIALS, 2024, 7 (04) : 3499 - 3514
  • [5] DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras
    Zhang, Xiaoyu
    Luukkonen, Lena M.
    Eissler, Christie L.
    Crowley, Vincent M.
    Yamashita, Yu
    Schafroth, Michael A.
    Kikuchi, Shota
    Weinstein, David S.
    Symons, Kent T.
    Nordin, Brian E.
    Rodriguez, Joe L.
    Wucherpfennig, Thomas G.
    Bauer, Ludwig G.
    Dix, Melissa M.
    Stamos, Dean
    Kinsella, Todd M.
    Simon, Gabriel M.
    Baltgalvis, Kristen A.
    Cravatt, Benjamin F.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (13) : 5141 - 5149
  • [6] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
    Li, Xin
    Song, Yongcheng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [7] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
    Xin Li
    Yongcheng Song
    Journal of Hematology & Oncology, 13
  • [8] Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design
    Chen, Yu
    Liu, Fengyuan
    Pal, Samira
    Hu, Quanyin
    CHEMICAL SOCIETY REVIEWS, 2024, 53 (19) : 9582 - 9608
  • [9] Therapy for schwannomas using AAV-P0-caspase and exosome-mediated delivery of therapeutic RNA/protein
    Breakeifeld, Xandra
    Prabhakar, Shilpa
    Sena-Esteves, Miguel
    Saydam, Okay
    Brenner, Gary
    HUMAN GENE THERAPY, 2012, 23 (10) : A18 - A18
  • [10] Programmable Circular Multivalent Nanobody-Targeting Chimeras (mNbTACs) for Multireceptor-Mediated Protein Degradation and Targeted Drug Delivery
    Jiang, Shiqi
    Lv, Xinru
    Ouyang, Zhenlin
    Chi, Hongli
    Zeng, Yuchen
    Wang, Yani
    He, Jiaxuan
    Chen, Jinling
    Chen, Jingyi
    An, Keli
    Cheng, Ming
    Wen, Yurong
    Li, Juan
    Zhang, Penghui
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (52)
12